FSGS recurrence in adults after renal transplantation

BioMed Research International

Volumn 2016, Issue , 2016, Pages

  Rudnicki, Michael ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ANGIOTENSIN 1 RECEPTOR; BETA3 INTEGRIN; BIOLOGICAL MARKER; CYCLOSPORIN; NEPHRIN; IMMUNOSUPPRESSIVE AGENT; RITUXIMAB;

ACUTE KIDNEY FAILURE; ALLOGRAFT; CONGENITAL NEPHROTIC SYNDROME; FOCAL GLOMERULOSCLEROSIS; GENETIC SCREENING; GENOTYPE PHENOTYPE CORRELATION; GRAFT SURVIVAL; HIGH RISK PATIENT; HISTOLOGY; HUMAN; HYPOALBUMINEMIA; IMMUNOADSORPTION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; NEPHRECTOMY; PLASMAPHERESIS; PODOCYTE; POSTOPERATIVE COMPLICATION; PROGNOSIS; PROPHYLAXIS; RACE DIFFERENCE; RECURRENCE RISK; RECURRENT DISEASE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SYSTEMATIC REVIEW (TOPIC); ADULT; ADVERSE EFFECTS; AGE; ANIMAL; CHILD; DISEASE COURSE; DISEASE MODEL; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; MUTATION; PATHOLOGY; RAT; REGISTER; RISK FACTOR;

ADULT; AGE FACTORS; ANIMALS; CHILD; CYCLOSPORINE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MUTATION; PODOCYTES; POSTOPERATIVE COMPLICATIONS; RATS; RECURRENCE; REGISTRIES; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; RITUXIMAB;

EID: 84966309425     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2016/3295618     Document Type: Review

References (71)

1. V. D. D'Agati, F. J. Kaskel, and R. J. Falk, "Focal segmental glomerulosclerosis, "The New England Journal of Medicine, vol. 365, no. 25, pp. 2398-2411, 2011.
2. C. Kitiyakara, P. Eggers, and J. B. Kopp, "Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States, " American Journal of Kidney Diseases, vol. 44, no. 5, pp. 815-825, 2004.
3. M. J. Chun, S.M. Korbet, M.M. Schwartz, and E. J. Lewis, "Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants, " Journal of the American Society of Nephrology, vol. 15, no. 8, pp. 2169-2177, 2004.
4. J. R. Hoyer, R. L. Vernier, J. S. Najarian, L. Raij, R. L. Simmons, and A. F. Michael, "Recurrence of idiopathic nephrotic syndrome after renal transplantation, " The Lancet, vol. 300, no. 7773, pp. 343-348, 1972.
5. B. Y. Choy, T. M. Chan, and K. N. Lai, "Recurrent glomerulonephritis after kidney transplantation, " American Journal of Transplantation, vol. 6, no. 11, pp. 2535-2542, 2006.
6. S. J. Chadban, "Glomerulonephritis recurrence in the renal graft, " Journal of theAmerican Society of Nephrology, vol. 12, no. 2, pp. 394-402, 2001.
7. S. Hariharan, M. B. Adams, D. C. Brennan et al., "Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR), " Transplantation, vol. 68, no. 5, pp. 635-641, 1999.
8. S. Kaplan-Pavlovčǐc, D. Ferluga, A. Hvala, N. Chwatal-Lakǐc, A. F. Bren, and A. Vizjak, "Recurrent focal segmental glomerulosclerosis after renal transplantation: is early recurrent proteinuria always a surrogate marker for recurrence of the disease?" Transplantation Proceedings, vol. 34, no. 8, pp. 3122-3124, 2002.
9. J.-W. Chang, V. Pardo, J. Sageshima et al., "Podocyte foot process effacement in postreperfusion allograft biopsies correlates with early recurrence of proteinuria in focal segmental glomerulosclerosis, " Transplantation, vol. 93, no. 12, pp. 1238-1244, 2012.
10. K. C. Abbott, E. S. Sawyers, J. D. Oliver III et al., "Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States, " American Journal of Kidney Diseases, vol. 37, no. 2, pp. 366-373, 2001.
11. E. M. Briganti, G. R. Russ, J. J. McNeil, R. C. Atkins, and S. J. Chadban, "Risk of renal allograft loss from recurrent glomerulonephritis, "The New England Journal of Medicine, vol. 347, no. 2, pp. 103-109, 2002.
12. L. Gallon, J. Leventhal, A. Skaro, Y. Kanwar, and A. Alvarado, "Resolution of recurrent focal segmental glomerulosclerosis after retransplantation, " The New England Journal of Medicine, vol. 366, no. 17, pp. 1648-1649, 2012.
13. V. J. Savin, R. Sharma, M. Sharma et al., "Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis, " The New England Journal of Medicine, vol. 334, no. 14, pp. 878-883, 1996.
14. L. Le Berre, Y. Godfrin, E. Günther et al., "Extrarenal effects on the pathogenesis and relapse of idiopathic nephrotic syndrome in Buffalo/Mna rats, " The Journal of Clinical Investigation, vol. 109, no. 4, pp. 491-498, 2002.
15. J. Patrakka, V. Ruotsalainen, P. Reponen et al., "Recurrence of nephrotic syndrome in kidney grafts of patients with congenital nephrotic syndrome of the finnish type: role of nephrin, " Transplantation, vol. 73, no. 3, pp. 394-403, 2002.
16. R. Becker-Cohen, M. Bruschi, C. Rinat et al., "Recurrent nephrotic syndrome in homozygous truncating NPHS2 mutation is not due to anti-podocin antibodies, " American Journal of Transplantation, vol. 7, no. 1, pp. 256-260, 2007.
17. T. C. Jungraithmayr, K. Hofer, P. Cochat et al., "Screening for NPHS2 mutations may help predict FSGS recurrence after transplantation, " Journal of the American Society of Nephrology, vol. 22, no. 3, pp. 579-585, 2011.
18. S. Weber, O. Gribouval, E. L. Esquivel et al., "NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence, " Kidney International, vol. 66, no. 2, pp. 571-579, 2004.
19. R. Bertelli, F. Ginevri, G. Caridi et al., "Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin, " American Journal of Kidney Diseases, vol. 41, no. 6, pp. 1314-1321, 2003.
20. C. Wei, H. Trachtman, J. Li et al., "Circulating suPAR in two cohorts of primary FSGS, " Journal of the American Society of Nephrology, vol. 23, no. 12, pp. 2051-2059, 2012.
21. C. Wei, S. ElHindi, J. Li et al., "Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis, " Nature Medicine, vol. 17, no. 8, pp. 952-960, 2011.
22. N. Alachkar, G. Gupta, and R. A. Montgomery, "Angiotensin antibodies and focal segmental glomerulosclerosis, " The New England Journal of Medicine, vol. 368, no. 10, pp. 971-973, 2013.
23. D. S. Charba, R. C. Wiggins, M. Goyal et al., "Antibodies to protein tyrosine phosphatase receptor type O (PTPro) increase glomerular albumin permeability (P(alb)), " American Journal of Physiology-Renal Physiology, vol. 297, no. 1, pp. F138-F144, 2009.
24. L. Musante, G. Candiano, M. Bruschi et al., "Circulating antiactin and anti-ATP synthase antibodies identify a sub-set of patients with idiopathic nephrotic syndrome, " Clinical and Experimental Immunology, vol. 141, no. 3, pp. 491-499, 2005.
25. M. Vinai, P. Waber, and M. G. Seikaly, "Recurrence of focal segmental glomerulosclerosis in renal allograft: an in-depth review, " Pediatric Transplantation, vol. 14, no. 3, pp. 314-325, 2010.
26. L. J. Hickson, M. Gera, H. Amer et al., "Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence, " Transplantation, vol. 87, no. 8, pp. 1232-1239, 2009.
27. A. Sener, A. J. Bella, C. Nguan, P. P. W. Luke, and A. A. House, "Focal segmental glomerular sclerosis in renal transplant recipients: predicting early disease recurrence may prolong allograft function, " Clinical Transplantation, vol. 23, no. 1, pp. 96-100, 2009.
28. A. Tejani and D. H. Stablein, "Recurrence of focal segmental glomerulosclerosis posttransplantation: a special report of the NorthAmericanPediatricRenal Transplant Cooperative study, " Journal of the American Society of Nephrology, vol. 2, supplement, no. 12, pp. S258-S263, 1992.
29. S. Weber and B. Tönshoff, "Recurrence of focal-segmental glomerulosclerosis in children after renal transplantation: clinical and genetic aspects, " Transplantation, vol. 80, supplement 1, pp. S128-S134, 2005.
30. R. DallAmico, G. Ghiggeri, M. Carraro et al., "Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children, " American Journal of Kidney Diseases, vol. 34, no. 6, pp. 1048-1055, 1999.
31. M. Fujisawa, K. Iijima, T. Ishimura et al., "Long-term outcome of focal segmental glomerulosclerosis after Japanese pediatric renal transplantation, " Pediatric Nephrology, vol. 17, no. 3, pp. 165-168, 2002.
32. W.Y. Ding, A. Koziell, H. J. McCarthy et al., "Initial steroid sensitivity in children with steroid-resistant nephrotic syndrome predicts post-transplant recurrence, " Journal of the American Society of Nephrology, vol. 25, no. 6, pp. 1342-1348, 2014.
33. R. Raafat, L. B. Travis, A. Kalia, and S. Diven, "Role of transplant induction therapy on recurrence rate of focal segmental glomerulosclerosis, " Pediatric Nephrology, vol. 14, no. 3, pp. 189-194, 2000.
34. J. Pascual, J. D. Mezrich, A. Djamali et al., "Alemtuzumab induction and recurrence of glomerular disease after kidney transplantation, " Transplantation, vol. 83, no. 11, pp. 1429-1434, 2007.
35. P.-T. T. Pham and P.-C. T. Pham, "The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence, " Nephrology Dialysis Transplantation, vol. 27, no. 7, pp. 2965-2971, 2012.
36. V. D. D'Agati, A. B. Fogo, J. A. Bruijn, and J. C. Jennette, "Pathologic classification of focal segmental glomerulosclerosis: a working proposal, " American Journal of Kidney Diseases, vol. 43, no. 2, pp. 368382, 2004.
37. G. Canaud, D. Dion, J. Zuber et al., "Recurrence of nephrotic syndrome after transplantation in a mixed population of children and adults: course of glomerular lesions and value of the Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS), " Nephrology Dialysis Transplantation, vol. 25, no. 4, pp. 1321-1328, 2010.
38. D. H. T. Ijpelaar, A. B. Farris, N. Goemaere et al., "Fidelity and evolution of recurrent FSGS in renal allografts, " Journal of the American Society of Nephrology, vol. 19, no. 11, pp. 2219-2224, 2008.
39. P. Cravedi, J. B. Kopp, and G. Remuzzi, "Recent progress in the pathophysiology and treatment of FSGS recurrence, " American Journal of Transplantation, vol. 13, no. 2, pp. 266-274, 2013.
40. C. Morath, C. Wei, S. Macher-Goeppinger, V. Schwenger, M. Zeier, and J. Reiser, "Management of severe recurrent focal segmental glomerulosclerosis through circulating soluble urokinase receptor modification, " American Journal of Therapeutics, vol. 20, no. 2, pp. 226-229, 2013.
41. S. Beaudreuil, X. Zhang, F. Kriaa et al., "Protein A immunoadsorption cannot significantly remove the soluble receptor of urokinase from sera of patients with recurrent focal segmental glomerulosclerosis, " Nephrology Dialysis Transplantation, vol. 29, no. 2, pp. 458-463, 2014.
42. M. Thuno, B. MacHo, and J. Eugen-Olsen, "suPAR: the molecular crystal ball, " Disease Markers, vol. 27, no. 3-4, pp. 157-172, 2009.
43. R. J. H. Maas, J. F. M. Wetzels, and J. K. J. Deegens, "Serumsoluble urokinase receptor concentration in primary FSGS, " Kidney International, vol. 81, no. 10, pp. 1043-1044, 2012.
44. S. S. Hayek, S. Sever, Y. A. Ko et al., "Soluble urokinase receptor and chronic kidney disease, "The New England Journal of Medicine, vol. 373, no. 20, pp. 1916-1925, 2015.
45. H. Trachtman, "suPAR and team nephrology, " BMC Medicine, vol. 12, article 82, 2014.
46. M. Delville, T. K. Sigdel, C. Wei et al., "A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation, " Science Translational Medicine, vol. 6, no. 256, p. 256ra136, 2014.
47. S. W. Zimmerman, "Plasmapheresis and dipyridamole for recurrent focal glomerular sclerosis, " Nephron, vol. 40, no. 2, pp. 241-245, 1985.
48. C. Ponticelli, "Recurrence of focal segmental glomerular sclerosis (FSGS) after renal transplantation, " Nephrology Dialysis Transplantation, vol. 25, no. 1, pp. 25-31, 2010.
49. R. Y. Gohh, A. F. Yango, P. E. Morrissey et al., "Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients, " American Journal of Transplantation, vol. 5, no. 12, pp. 2907-2912, 2005.
50. H. Hubsch, B. Montané, C. Abitbol et al., "Recurrent focal glomerulosclerosis in pediatric renal allografts: the miami experience, " Pediatric Nephrology, vol. 20, no. 2, pp. 210-216, 2005.
51. F. Fencl, E. Šimková, K. Vondrák et al., "Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis after renal transplantation treated with plasmapheresis and immunoadsorption: case reports, " Transplantation Proceedings, vol. 39, no. 10, pp. 3488-3490, 2007.
52. A. Belson, P. D. Yorgin, A. Y. Al-Uzri, O. Salvatierra, J. Higgins, and S. R. Alexander, "Long-term plasmapheresis and protein A column treatment of recurrent FSGS, " Pediatric Nephrology, vol. 16, no. 12, pp. 985-989, 2001.
53. R. Salomon, M.-F. Gagnadoux, and P. Niaudet, "Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in children, " Transplantation, vol. 75, no. 6, pp. 810-814, 2003.
54. R. H. Raafat, A. Kalia, L. B. Travis, and S. C. Diven, "Highdose oral cyclosporin therapy for recurrent focal segmental glomerulosclerosis in children, " American Journal of Kidney Diseases, vol. 44, no. 1, pp. 50-56, 2004.
55. A. Fornoni, J. Sageshima, C. Wei et al., "Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis, " Science TranslationalMedicine, vol. 3, no. 85, Article ID85ra46, 2011.
56. M. D. Pescovitz, B. K. Book, and R. A. Sidner, "Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment, "The New England Journal ofMedicine, vol. 354, no. 18, pp. 1961-1963, 2006.
57. C. E. Araya and V. R. Dharnidharka, "The factors that may predict response to rituximab therapy in recurrent focal segmental glomerulosclerosis: a systematic review, " Journal of Transplantation, vol. 2011, Article ID 374213, 7 pages, 2011.
58. P. Cravedi, P. Ruggenenti, and G. Remuzzi, "Low-dose rituximab for posttransplant recurrent membranous nephropathy, " American Journal of Transplantation, vol. 10, no. 5, p. 1336, 2010.
59. G. Tsagalis, E. Psimenou, L. Nakopoulou, and A. Laggouranis, "Combination treatment with plasmapheresis and rituximab for recurrent focal segmental glomerulosclerosis after renal transplantation, " Artificial Organs, vol. 35, no. 4, pp. 420-425, 2011.
60. D. Hristea, K. Hadaya, N. Marangon et al., "Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab, " Transplant International, vol. 20, no. 1, pp. 102-105, 2007.
61. S. Mizuiri, T. Kawamura, M. Miyagi et al., "Post-transplant early recurrent proteinuria in patientswith focal glomerulosclerosis-Angiotensin II immunostaining and treatment outcome, " Clinical Transplantation, vol. 19, supplement 14, pp. 12-19, 2005.
62. G. Montagnino, A. Tarantino, G. Banfi, M. Maccario, L. Costamagna, and C. Ponticelli, "Double recurrence of FSGS after two renal transplants with complete regression after plasmapheresis and ACE inhibitors, " Transplant International, vol. 13, no. 2, pp. 166-168, 2000.
63. V. Freiberger, K. Amann, U. Heemann, and H. Frank, "Effect of a triple blockade of the renin-angiotensin-system in recurrent focal segmental glomerulosclerosis after kidney transplantation, " Transplant International, vol. 22, no. 11, pp. 1110-1113, 2009.
64. V. J. Savin, E. T. McCarthy, R. Sharma, D. Charba, and M. Sharma, "Galactose binds to focal segmental glomerulosclerosis permeability factor and inhibits its activity, " Translational Research, vol. 151, no. 6, pp. 288-292, 2008.
65. C.-C. Yu, A. Fornoni, A. Weins et al., "Abatacept in B7-1-positive proteinuric kidney disease, " The New England Journal of Medicine, vol. 369, no. 25, pp. 2416-2423, 2013.
66. E. H. Garin, J. Reiser, G. Cara-Fuentes et al., "Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis, " PediatricNephrology, vol. 30, no. 3, pp. 469-477, 2015.
67. N. Alachkar, N. Carter-Monroe, and J. Reiser, "Abatacept in B7-1-positive proteinuric kidney disease, "The New England Journal of Medicine, vol. 370, no. 13, pp. 1263-1264, 2014.
68. O. Alkandari, N. Nampoory, P. Nair et al., "Recurrent focal segmental glomerulosclerosis and abatacept: case report, " Experimental and Clinical Transplantation, 2014.
69. M. A. Baum, D. M. Stablein, V. M. Panzarino, A. Tejani, W. E. Harmon, and S. R. Alexander, "Loss of living donor renal allograft survival advantage in children with focal segmental glomerulosclerosis, " Kidney International, vol. 59, no. 1, pp. 328-333, 2001.
70. E. J. Nehus, J. W. Goebel, P. S. Succop, and E. C. Abraham, "Focal segmental glomerulosclerosis in children: multivariate analysis indicates that donor type does not alter recurrence risk, " Transplantation, vol. 96, no. 6, pp. 550-554, 2013.
71. D. M. Cibrik, B. Kaplan, D. A. Campbell, and H.-U. Meier-Kriesche, "Renal allograft survival in transplant recipients with focal segmental glomerulosclerosis, " American Journal of Transplantation, vol. 3, no. 1, pp. 64-67, 2003.